FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Davis Chaim

2. Date of Event Requiring Statement (MM/DD/YYYY)
7/5/2017 

3. Issuer Name and Ticker or Trading Symbol

AMERICAN BIO MEDICA CORP [ABMC]

(Last)        (First)        (Middle)

80 BRAINARD ROAD

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__ X __ Director                            _____ 10% Owner
_____ Officer (give title below)          _____ Other (specify below)

(Street)

WEST HARTFORD, CT 06117       

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed (MM/DD/YYYY)

 

6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person


Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Shares   1949915   I   By Revach Fund LP   (1)

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Non Statutory Option   4/26/2014   (2) 4/26/2023   Common Shares   50000   $0.18   D    

Explanation of Responses:
(1)  The Common Shares are in the name of Revach Fund, LP. The reporting person is a managing member of Revach Group, LLC, which operates as the general partner of the Revach Fund, LP.
(2)  The stock option was issued on 4/26/2013 and vested over 2 years. It became 100% exercisable on 4/26/2015.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Davis Chaim
80 BRAINARD ROAD
WEST HARTFORD, CT 06117
X



Signatures
Chaim Davis 8/2/2017
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
American Bio Medica (CE) (USOTC:ABMC)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more American Bio Medica (CE) Charts.
American Bio Medica (CE) (USOTC:ABMC)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more American Bio Medica (CE) Charts.